Analysis of the tumor microenvironment in ineffective patients of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma

被引：0
|
作者：
Kobayashi, Kazufumi
Ogasawara, Sadahisa
Ishino, Takamasa
Unozawa, Hidemi
Nakagawa, Miyuki
Fujiwara, Kisako
Sakuma, Takafumi
Fujita, Naoto
Kanzaki, Hiroaki
Koroki, Keisuke
Nakamura, Masato
Kiyono, Soichiro
Kanogawa, Naoya
Kondo, Takayuki
Saito, Tomoko
Nakagawa, Ryo
Nakamoto, Shingo
Muroyama, Ryosuke
Chiba, Tetsuhiro
Kato, Naoya
机构：
[1] Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan
[2] Chiba Univ, Grad Sch Med, Chiba, Japan
[3] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.468
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
468
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Atezolizumab plus bevacizumab in Child-Pugh B advanced hepatocellular carcinoma patients
    Kim, Hyeyeong
    Cheon, Jaekyung
    Ha, Yeongjung
    Kim, Han Sang
    Kim, Chang Gon
    Kim, Ilhwan
    Kim, Chan
    Jung, Sang-Hoon
    Chon, Hong Jae
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [12] Combination of Radiotherapy and Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study
    Hur, Y. J.
    Kim, J.
    Seong, J.
    Lee, C. K.
    Kim, B. K.
    Kim, D. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E304 - E305
  • [13] Atezolizumab plus bevacizumab in patients with child-Pugh B advanced hepatocellular carcinoma
    Cheon, Jaekyung
    Kim, Hyeyeong
    Kim, Han Sang
    Kim, Chang Gon
    Kim, Ilhwan
    Kang, Beodeul
    Kim, Chan
    Jung, Sanghoon
    Ha, Yeonjung
    Chon, Hong Jae
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [14] Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience
    Sinner, Friedrich
    Pinter, Matthias
    Scheiner, Bernhard
    Ettrich, Thomas Jens
    Sturm, Niklas
    Gonzalez-Carmona, Maria A.
    Waidmann, Oliver
    Finkelmeier, Fabian
    Himmelsbach, Vera
    De Toni, Enrico N.
    Ben Khaled, Najib
    Mohr, Raphael
    Fruendt, Thorben Wilhelm
    Kuetting, Fabian
    van Boemmel, Florian
    Lieb, Sabine
    Krug, Sebastian
    Bettinger, Dominik
    Schultheiss, Michael
    Jochheim, Leonie S.
    Best, Jan
    Mueller, Christian
    Keitel, Verena
    Venerito, Marino
    CANCERS, 2022, 14 (23)
  • [15] Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis
    Hatanaka, Takeshi
    Hiraoka, Atsushi
    Tada, Toshifumi
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ochi, Hironori
    Yasuda, Satoshi
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishimura, Takashi
    Kakizaki, Satoru
    Shimada, Noritomo
    Kawata, Kazuhito
    Tanaka, Takaaki
    Ohama, Hideko
    Nouso, Kazuhiro
    Morishita, Asahiro
    Tsutsui, Akemi
    Nagano, Takuya
    Itokawa, Norio
    Okubo, Tomomi
    Arai, Taeang
    Imai, Michitaka
    Naganuma, Atsushi
    Koizumi, Yohei
    Nakamura, Shinichiro
    Joko, Kouji
    Iijima, Hiroko
    Hiasa, Yoichi
    Kumada, Takashi
    HEPATOLOGY RESEARCH, 2022, 52 (05) : 462 - 470
  • [16] Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
    Yano, Shigeki
    Kawaoka, Tomokazu
    Johira, Yusuke
    Miura, Ryoichi
    Kosaka, Masanari
    Shirane, Yuki
    Murakami, Serami
    Amioka, Kei
    Naruto, Kensuke
    Ando, Yuwa
    Kosaka, Yumi
    Yamaoka, Kenji
    Kodama, Kenichiro
    Uchikawa, Shinsuke
    Fujino, Hatsue
    Ohno, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Okamoto, Wataru
    Yamauchi, Masami
    Imamura, Michio
    Mori, Keiichi
    Arihiro, Kouji
    Kuroda, Shintaro
    Kobayashi, Tsuyoshi
    Ohdan, Hideki
    Aikata, Hiroshi
    MEDICINE, 2021, 100 (42) : E27576
  • [17] Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
    Finn, Richard S.
    Qin, Shukui
    Ikeda, Masafumi
    Galle, Peter R.
    Ducreux, Michel
    Kim, Tae-You
    Kudo, Masatoshi
    Breder, Valeriy
    Merle, Philippe
    Kaseb, Ahmed O.
    Li, Daneng
    Verret, Wendy
    Xu, Derek-Zhen
    Hernandez, Sairy
    Liu, Juan
    Huang, Chen
    Mulla, Sohail
    Wang, Yulei
    Lim, Ho Yeong
    Zhu, Andrew X.
    Cheng, Ann-Lii
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20): : 1894 - 1905
  • [18] Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
    Lee, Kyung-Hun
    Lee, Michael S.
    LANCET ONCOLOGY, 2020, 21 (09): : E413 - E413
  • [19] Extracellular Vesicles May Predict Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma
    Egerer, Mara
    Schuch, Kathrin
    Schoeler, David
    Artusa, Fabian
    Puengel, Tobias
    Holtman, Theresa Maria
    Loosen, Sven H.
    Demir, Muenevver
    Wree, Alexander
    Luedde, Tom
    Tacke, Frank
    Roderburg, Christoph
    Mohr, Raphael
    CANCERS, 2024, 16 (21)
  • [20] Exploring the efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes
    Kanzaki, Hiroaki
    Ishino, Takamasa
    Ogasawara, Sadahisa
    Yumita, Sae
    Nakagawa, Miyuki
    Kojima, Ryuta
    Koroki, Keisuke
    Inoue, Masanori
    Kobayashi, Kazufumi
    Kanogawa, Naoya
    Kiyono, Soichiro
    Nakamura, Masato
    Kondo, Takayuki
    Nakamoto, Shingo
    Takayashiki, Tsukasa
    Lin, Jason
    Kawazu, Masahito
    Komuta, Mina
    Ikeda, Jun-ichiro
    Ohtsuka, Masayuki
    Togashi, Yosuke
    Kato, Naoya
    CANCER RESEARCH, 2024, 84 (06)
12345